• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Sofinnova Partners

Sofinnova et al. invest £1.3m in Synthace

Sofinnova Partners has led a ТЃ1.3m funding round for Synthace, a London-based applied synthetic bioengineering company, alongside a syndicate of angel investors.

  • UK / Ireland
  • 25 September 2013
Omega Funds leads $10m round for SpineVision

Omega Funds has led a $10m funding round for French medical devices provider SpineVision, which also included investments from two other new backers.

  • France
  • 08 May 2013
Sofinnova backs Auris Medical with CHF 47.1m

French VC Sofinnova Partners has joined US-based Sofinnova Ventures in a CHF 47.1m funding round for Auris Medical.

  • DACH
  • 16 April 2013
Sofinnova et al. invest in MetGen

Sofinnova Partners has led a тЌ2.2m round for Finnish start-up MetGen, with participation from Finnish Industry Investment and Finnvera.

  • Nordics
  • 11 February 2013
Sofinnova closes seventh fund on €240m

Sofinnova Partners has closed its seventh fund on the vehicle's €240m hard-cap.

  • France
  • 11 December 2012
Sofinnova closes largest European life sciences fund in years
Sofinnova closes largest European life sciences fund in years

Sofinnova Partners is due to announce a final close on its seventh life sciences fund in the second week of December, unquote” has learned. Kimberly Romaine reports

  • Fundraising
  • 12 November 2012
Sofinnova Partners lists DBV

Paris-based Sofinnova Partners has listed DBV Technologies, raising €40.5m in the IPO on NYSE Euronext Paris.

  • Exits
  • 29 March 2012
Sofinnova and Morningside back NuCana BioMed

Sofinnova Partners has led a series-A round for biopharmaceutical company NuCana BioMed alongside Morningside Ventures and other investors, with financing totaling ТЃ6.74m.

  • UK / Ireland
  • 29 November 2011
Sofinnova Partners backs Hookipa Biotech

Paris-based Sofinnova Partners has led a €7m series-A financing for biotechnology firm Hookipa Biotech.

  • DACH
  • 17 October 2011
Sofinnova leads £6m investment in Mission Therapeutics

Sofinnova Partners has led a ТЃ6m funding round for Cambridge-based drug development company Mission Therapeutics.

  • UK / Ireland
  • 25 August 2011
234
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013